CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies ...

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for ...

Fortress Biotech, Inc. has announced the acquisition of its subsidiary Checkpoint Therapeutics, Inc. by Sun Pharmaceutical Industries Limited, which closed on May 30, 2025, after receiving ...

The biotech index has only produced a positive return in one of the past five years and hasn’t produced a double-digit return in any of them. Too many of the biotechs that went public in the ...

23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company that has used DNA ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry ...

M&A is back, but nothing in biotech is neat or simple Plus: Drugmakers shouldn’t be too worried about FDA delays — yet Molly Ferguson/STAT By Adam Feuerstein May 1, 2025 Senior Writer, Biotech ...

"New tool for cutting DNA: Promising prospects for biotechnology." ScienceDaily. ScienceDaily, 14 April 2025. <www.sciencedaily.com / releases / 2025 / 04 / 250414124458.htm>.

Empress Therapeutics is halving its team, letting go of 23 employees as the biotech works to get its small-molecule science into the clinic. The Flagship Pioneering biotech has 20 remaining ...

Cambridge, MA, Mar 3, 2025 --- Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (“Tenacia”), a ...